Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

Completed · Phase 2 · Has a placebo group

Conditions studied: Ocular Redness

In brief

The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects

Key facts

Study ID

NCT01675609

Run by

Eye Therapies, LLC

People needed

57

Starts

2012-08-01

Last updated by the study team

2014-07-31

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Be at least 40 years of age
• Must have normal ocular health
• Must have history of redness relief drop use or desire to use

You may not qualify if…

• Must not have any ocular/systemic health problems
• Must agree to avoid disallowed medications

Where it is running

• Ora, Inc. — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.